Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020091440 - COMPOSITION FOR IMPROVING SKIN BARRIER DAMAGE AND/OR ALLEVIATING SKIN INFLAMMATION, CONTAINING 3,5-DICAFFEOYLQUINIC ACID AS ACTIVE INGREDIENT

Publication Number WO/2020/091440
Publication Date 07.05.2020
International Application No. PCT/KR2019/014547
International Filing Date 31.10.2019
IPC
A61K 31/192 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19Carboxylic acids, e.g. valproic acid
192having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 36/28 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
A61K 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61P 17/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61K 8/368 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
30containing organic compounds
33containing oxygen
36Carboxylic acids; Salts or anhydrides thereof
368with carboxyl groups directly bound to carbon atoms of aromatic rings
Applicants
  • 고려대학교 산학협력단 KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION [KR]/[KR]
  • 한국과학기술연구원 KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY [KR]/[KR]
Inventors
  • 서홍석 SEO, Hong Seog
  • 이용직 LEE, Yong Jik
  • 김형자 KIM, Hyoung Ja
  • 진창배 JIN, Chang Bae
Agents
  • 특허법인 다해 DAHAI INTERNATIONAL PATENT & LAW FIRM
Priority Data
10-2018-013221631.10.2018KR
Publication Language Korean (KO)
Filing Language Korean (KO)
Designated States
Title
(EN) COMPOSITION FOR IMPROVING SKIN BARRIER DAMAGE AND/OR ALLEVIATING SKIN INFLAMMATION, CONTAINING 3,5-DICAFFEOYLQUINIC ACID AS ACTIVE INGREDIENT
(FR) COMPOSITION PERMETTANT D'AMÉLIORER L'ENDOMMAGEMENT DE LA BARRIÈRE CUTANÉE ET/OU DE SOULAGER L'INFLAMMATION CUTANÉE, CONTENANT DE L'ACIDE 3,5-DICAFÉOYLQUINIQUE EN TANT QUE PRINCIPE ACTIF
(KO) 3,5-디카페오일퀴닉산을 유효성분으로 함유하는 피부장벽 손상 개선용 및/또는 피부 염증 완화용 조성물
Abstract
(EN)
The present invention relates to a composition for improving skin barrier damage and/or alleviating skin inflammation, and enables the improvement of skin barrier damage and the alleviation of skin inflammation through the application of Aster glehni extract-isolated 3,5-dicaffeoylquinic acid as an active ingredient of a cosmetic composition and a pharmaceutical composition, thereby having effects of preventing and improving atopic dermatitis.
(FR)
La présente invention concerne une composition destinée à améliorer l'endommagement de la barrière cutanée et/ou à soulager l'inflammation cutanée, et permet l'amélioration de l'endommagement de la barrière cutanée et le soulagement de l'inflammation cutanée par l'application d'acide 3,5-dicaféoylquinique isolé d'un extrait d'Aster glehni en tant que principe actif d'une composition cosmétique et d'une composition pharmaceutique, présentant ainsi des effets de prévention et d'amélioration de la dermatite atopique.
(KO)
본 발명은 피부장벽 손상 개선용 및/또는 피부 염증 완화용 조성물에 관한 것으로, 섬쑥부쟁이(Aster glehni) 추출물로부터 분리된 3,5-디카페오일퀴닉산(3,5-dicaffeoylquinic acid)을 화장료 조성물 및 약제학적 조성물의 유효성분으로 도입함으로써, 피부장벽 손상을 개선하고, 피부염증을 완화하여 아토피 피부염에 대한 예방 및 개선 효과가 있다.
Latest bibliographic data on file with the International Bureau